Recently, there has been uproar in the prostate cancer community over the FDA's handling of the approval of Provenge. The conflict between patients looking for new treatments and the FDA's attempt to protect the public is one with a long-standing history and with complex dynamics. The new activism of the prostrate cancer community is one [...]
We survivors should always try to remember that advanced prostate cancer tries our caregivers in ways we do not always consider. We all know that they care and we all know they are worried. The longer our battle goes on, especially if our cancer is in something of a healthy balance (stabilized PSA) the more [...]
Today my wife told me that we would have to have two more children if we had any more at all. Her reasoning is that by the time a second child is born, assuming she got pregnant today, Devin will be five-ish and the new baby would need someone closer to his/her age to play [...]
From clinical cancer research: Rethinking Therapeutic Cancer Vaccine Trials Ongoing therapeutic cancer vaccine trials have yet to show evidence of vaccines spurring a patient's immune system to shrink tumors -- yet patients who receive these vaccines in trials tend to live longer and respond better to subsequent treatment. In the July 1 issue of Clinical [...]
Imagine taking a drug that circulates in your body until it finds your cancer. Once a cancer cell is found it directly attacks the cell by delivering radiation directly into the cell. The cancer cell is destroyed with minimal collateral damage to your healthy normal cells! If you suffer from the hard to treat lymphoma, [...]